Skip to main content
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1997 Aug;17(8):4238–4248. doi: 10.1128/mcb.17.8.4238

C/EBP factor suppression of inhibition of type II secreted phospholipase A2 promoter in HepG2 cells: possible role of single-strand binding proteins.

Q Fan 1, M Paradon 1, C Salvat 1, G Bereziat 1, J L Olivier 1
PMCID: PMC232277  PMID: 9234681

Abstract

We previously reported that the type II secreted phospholipase A2 (sPLA2) promoter from positions (-326 to +20) ([-326;+20] promoter) is negatively regulated by two adjacent regulatory elements, C (-210 to -176) and D (-247 to -210). This study examines in greater detail the way in which this negative regulation operates. Successive 5' deletions of the [-326;+20] type II sPLA2 promoter indicated that the region upstream of position -195 inhibits the transcription activity sixfold in HepG2 cells but not in HeLa cells. Although the whole [-326;-176] region decreased the activity of a heterologous thymidine kinase promoter, this effect was orientation and position sensitive. C/EBP beta, C/EBP alpha, and C/EBP delta, which bind to element C, prevented the inhibition of promoter activity. Electrophoretic mobility shift experiments identified the binding of NF1-like proteins to the [-225;-218] site, which overlaps an insulin response-like sequence, 5'-TGTTTTG-3'. This sequence bound a factor which also recognized the promoters of the apolipoproteins C-III and A-II. Substitutions preventing the binding of this factor or the NF1-like proteins did not increase the transcription activity, but substitution in the [-217;-204] sequence blocked the transcription inhibition. This sequence did not bind any double-strand binding factor, but its antisense strand is critical for the binding of single-strand binding proteins to the [-232;-191] region. We therefore suggest that these single-strand binding proteins are involved in the inhibitory mechanism.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams A. D., Choate D. M., Thompson M. A. NF1-L is the DNA-binding component of the protein complex at the peripherin negative regulatory element. J Biol Chem. 1995 Mar 24;270(12):6975–6983. doi: 10.1074/jbc.270.12.6975. [DOI] [PubMed] [Google Scholar]
  2. Alam T., An M. R., Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem. 1992 Mar 15;267(8):5021–5024. [PubMed] [Google Scholar]
  3. Avitahl N., Calame K. The C/EBP family of proteins distorts DNA upon binding but does not introduce a large directed bend. J Biol Chem. 1994 Sep 23;269(38):23553–23562. [PubMed] [Google Scholar]
  4. Baumann H., Morella K. K., Campos S. P., Cao Z., Jahreis G. P. Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes. J Biol Chem. 1992 Sep 25;267(27):19744–19751. [PubMed] [Google Scholar]
  5. Borgmeyer U., Nowock J., Sippel A. E. The TGGCA-binding protein: a eukaryotic nuclear protein recognizing a symmetrical sequence on double-stranded linear DNA. Nucleic Acids Res. 1984 May 25;12(10):4295–4311. doi: 10.1093/nar/12.10.4295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Budhram-Mahadeo V., Morris P. J., Lakin N. D., Dawson S. J., Latchman D. S. The different activities of the two activation domains of the Brn-3a transcription factor are dependent on the context of the binding site. J Biol Chem. 1996 Apr 12;271(15):9108–9113. doi: 10.1074/jbc.271.15.9108. [DOI] [PubMed] [Google Scholar]
  7. Cao Z., Umek R. M., McKnight S. L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991 Sep;5(9):1538–1552. doi: 10.1101/gad.5.9.1538. [DOI] [PubMed] [Google Scholar]
  8. Cardot P., Pastier D., Lacorte J. M., Mangeney M., Zannis V. I., Chambaz J. Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: a negative regulatory effect is reversed by GABP, an Ets-related protein. Biochemistry. 1994 Oct 11;33(40):12139–12148. doi: 10.1021/bi00206a017. [DOI] [PubMed] [Google Scholar]
  9. Costa R. H., Grayson D. R., Darnell J. E., Jr Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol Cell Biol. 1989 Apr;9(4):1415–1425. doi: 10.1128/mcb.9.4.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Crowl R. M., Stoller T. J., Conroy R. R., Stoner C. R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991 Feb 5;266(4):2647–2651. [PubMed] [Google Scholar]
  11. Davis-Smyth T., Duncan R. C., Zheng T., Michelotti G., Levens D. The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J Biol Chem. 1996 Dec 6;271(49):31679–31687. doi: 10.1074/jbc.271.49.31679. [DOI] [PubMed] [Google Scholar]
  12. Desbois C., Massé T., Madjar J. J. Optimization of the CAT assay procedure by determining the initial rate of the enzymatic reaction. Trends Genet. 1992 Sep;8(9):300–301. doi: 10.1016/0168-9525(92)90260-b. [DOI] [PubMed] [Google Scholar]
  13. Descombes P., Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 1991 Nov 1;67(3):569–579. doi: 10.1016/0092-8674(91)90531-3. [DOI] [PubMed] [Google Scholar]
  14. Gil G., Smith J. R., Goldstein J. L., Slaughter C. A., Orth K., Brown M. S., Osborne T. F. Multiple genes encode nuclear factor 1-like proteins that bind to the promoter for 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8963–8967. doi: 10.1073/pnas.85.23.8963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gorski K., Carneiro M., Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell. 1986 Dec 5;47(5):767–776. doi: 10.1016/0092-8674(86)90519-2. [DOI] [PubMed] [Google Scholar]
  16. Gounari F., De Francesco R., Schmitt J., van der Vliet P., Cortese R., Stunnenberg H. Amino-terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication. EMBO J. 1990 Feb;9(2):559–566. doi: 10.1002/j.1460-2075.1990.tb08143.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Grossmann M. E., Tindall D. J. The androgen receptor is transcriptionally suppressed by proteins that bind single-stranded DNA. J Biol Chem. 1995 May 5;270(18):10968–10975. doi: 10.1074/jbc.270.18.10968. [DOI] [PubMed] [Google Scholar]
  18. Hadzopoulou-Cladaras M., Cardot P. Identification of a cis-acting negative DNA element which modulates human hepatic triglyceride lipase gene expression. Biochemistry. 1993 Sep 21;32(37):9657–9667. doi: 10.1021/bi00088a018. [DOI] [PubMed] [Google Scholar]
  19. Huang J. H., Liao W. S. Induction of the mouse serum amyloid A3 gene by cytokines requires both C/EBP family proteins and a novel constitutive nuclear factor. Mol Cell Biol. 1994 Jul;14(7):4475–4484. doi: 10.1128/mcb.14.7.4475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ito K., Sato K., Endo H. Cloning and characterization of a single-stranded DNA binding protein that specifically recognizes deoxycytidine stretch. Nucleic Acids Res. 1994 Jan 11;22(1):53–58. doi: 10.1093/nar/22.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kaufman R. J., Davies M. V., Pathak V. K., Hershey J. W. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol. 1989 Mar;9(3):946–958. doi: 10.1128/mcb.9.3.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kusk P., John S., Fragoso G., Michelotti J., Hager G. L. Characterization of an NF-1/CTF family member as a functional activator of the mouse mammary tumor virus long terminal repeat 5' enhancer. J Biol Chem. 1996 Dec 6;271(49):31269–31276. doi: 10.1074/jbc.271.49.31269. [DOI] [PubMed] [Google Scholar]
  23. Lai E., Prezioso V. R., Smith E., Litvin O., Costa R. H., Darnell J. E., Jr HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev. 1990 Aug;4(8):1427–1436. doi: 10.1101/gad.4.8.1427. [DOI] [PubMed] [Google Scholar]
  24. Landschulz W. H., Johnson P. F., Adashi E. Y., Graves B. J., McKnight S. L. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 1988 Jul;2(7):786–800. doi: 10.1101/gad.2.7.786. [DOI] [PubMed] [Google Scholar]
  25. Lee Y. M., Tsai W. H., Lai M. Y., Chen D. S., Lee S. C. Induction of liver alpha-1 acid glycoprotein gene expression involves both positive and negative transcription factors. Mol Cell Biol. 1993 Jan;13(1):432–442. doi: 10.1128/mcb.13.1.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lu S. Y., Rodriguez M., Liao W. S. YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol. 1994 Sep;14(9):6253–6263. doi: 10.1128/mcb.14.9.6253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Maire P., Wuarin J., Schibler U. The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science. 1989 Apr 21;244(4902):343–346. doi: 10.1126/science.2711183. [DOI] [PubMed] [Google Scholar]
  28. Meisterernst M., Rogge L., Foeckler R., Karaghiosoff M., Winnacker E. L. Structural and functional organization of a porcine gene coding for nuclear factor I. Biochemistry. 1989 Oct 3;28(20):8191–8200. doi: 10.1021/bi00446a034. [DOI] [PubMed] [Google Scholar]
  29. Michelotti E. F., Michelotti G. A., Aronsohn A. I., Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol. 1996 May;16(5):2350–2360. doi: 10.1128/mcb.16.5.2350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Minami T., Tojo H., Shinomura Y., Tarui S., Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut. 1992 Jul;33(7):914–921. doi: 10.1136/gut.33.7.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Müller G., Ruppert S., Schmid E., Schütz G. Functional analysis of alternatively spliced tyrosinase gene transcripts. EMBO J. 1988 Sep;7(9):2723–2730. doi: 10.1002/j.1460-2075.1988.tb03126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nevalainen T. J., Kortesuo P. T., Rintala E., Märki F. Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem. 1992 Sep;38(9):1824–1829. [PubMed] [Google Scholar]
  33. O'Brien R. M., Noisin E. L., Suwanichkul A., Yamasaki T., Lucas P. C., Wang J. C., Powell D. R., Granner D. K. Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol. 1995 Mar;15(3):1747–1758. doi: 10.1128/mcb.15.3.1747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ogami K., Hadzopoulou-Cladaras M., Cladaras C., Zannis V. I. Promoter elements and factors required for hepatic and intestinal transcription of the human ApoCIII gene. J Biol Chem. 1990 Jun 15;265(17):9808–9815. [PubMed] [Google Scholar]
  35. Ohmori M., Ohta M., Shimura H., Shimurat Y., Suzuki K., Kohn L. D. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor. Mol Endocrinol. 1996 Nov;10(11):1407–1424. doi: 10.1210/mend.10.11.8923467. [DOI] [PubMed] [Google Scholar]
  36. Olivier J. L., Fan Q., Salvat C., Ziari M., Kong L., Mangeney M., Bereziat G. Positive and negative hepatic regulation of the human type II phospholipase A2 gene. Biochemistry. 1994 Jun 14;33(23):7134–7145. doi: 10.1021/bi00189a017. [DOI] [PubMed] [Google Scholar]
  37. Osborn L., Kunkel S., Nabel G. J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336–2340. doi: 10.1073/pnas.86.7.2336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pan W. T., Liu Q. R., Bancroft C. Identification of a growth hormone gene promoter repressor element and its cognate double- and single-stranded DNA-binding proteins. J Biol Chem. 1990 Apr 25;265(12):7022–7028. [PubMed] [Google Scholar]
  39. Paonessa G., Gounari F., Frank R., Cortese R. Purification of a NF1-like DNA-binding protein from rat liver and cloning of the corresponding cDNA. EMBO J. 1988 Oct;7(10):3115–3123. doi: 10.1002/j.1460-2075.1988.tb03178.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Papazafiri P., Ogami K., Ramji D. P., Nicosia A., Monaci P., Cladaras C., Zannis V. I. Promoter elements and factors involved in hepatic transcription of the human ApoA-I gene positive and negative regulators bind to overlapping sites. J Biol Chem. 1991 Mar 25;266(9):5790–5797. [PubMed] [Google Scholar]
  41. Park K., Atchison M. L. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9804–9808. doi: 10.1073/pnas.88.21.9804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pei D. Q., Shih C. H. Transcriptional activation and repression by cellular DNA-binding protein C/EBP. J Virol. 1990 Apr;64(4):1517–1522. doi: 10.1128/jvi.64.4.1517-1522.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Poli V., Mancini F. P., Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell. 1990 Nov 2;63(3):643–653. doi: 10.1016/0092-8674(90)90459-r. [DOI] [PubMed] [Google Scholar]
  44. Ray A., Ray B. K. Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-beta and C/EBP-delta and their activation by phosphorylation. Mol Cell Biol. 1994 Jun;14(6):4324–4332. doi: 10.1128/mcb.14.6.4324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Roesler W. J., Crosson S. M., Vinson C., McFie P. J. The alpha-isoform of the CCAAT/enhancer-binding protein is required for mediating cAMP responsiveness of the phosphoenolpyruvate carboxykinase promoter in hepatoma cells. J Biol Chem. 1996 Apr 5;271(14):8068–8074. doi: 10.1074/jbc.271.14.8068. [DOI] [PubMed] [Google Scholar]
  46. Roy R. J., Guérin S. L. The 30-kDa rat liver transcription factor nuclear factor 1 binds the rat growth-hormone proximal silencer. Eur J Biochem. 1994 Feb 1;219(3):799–806. doi: 10.1111/j.1432-1033.1994.tb18560.x. [DOI] [PubMed] [Google Scholar]
  47. Santoro C., Mermod N., Andrews P. C., Tjian R. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature. 1988 Jul 21;334(6179):218–224. doi: 10.1038/334218a0. [DOI] [PubMed] [Google Scholar]
  48. Schoonjans K., Staels B., Devos P., Szpirer J., Szpirer C., Deeb S., Verhoeven G., Auwerx J. Developmental extinction of liver lipoprotein lipase mRNA expression might be regulated by an NF-1-like site. FEBS Lett. 1993 Aug 23;329(1-2):89–95. doi: 10.1016/0014-5793(93)80200-e. [DOI] [PubMed] [Google Scholar]
  49. Seilhamer J. J., Pruzanski W., Vadas P., Plant S., Miller J. A., Kloss J., Johnson L. K. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem. 1989 Apr 5;264(10):5335–5338. [PubMed] [Google Scholar]
  50. Smidt M. P., Russchen B., Snippe L., Wijnholds J., Ab G. Cloning and characterisation of a nuclear, site specific ssDNA binding protein. Nucleic Acids Res. 1995 Jul 11;23(13):2389–2395. doi: 10.1093/nar/23.13.2389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sun S., Stoflet E. S., Cogan J. G., Strauch A. R., Getz M. J. Negative regulation of the vascular smooth muscle alpha-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins. Mol Cell Biol. 1995 May;15(5):2429–2436. doi: 10.1128/mcb.15.5.2429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tanuma Y., Nakabayashi H., Esumi M., Endo H. A silencer element for the lipoprotein lipase gene promoter and cognate double- and single-stranded DNA-binding proteins. Mol Cell Biol. 1995 Jan;15(1):517–523. doi: 10.1128/mcb.15.1.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Trautwein C., Caelles C., van der Geer P., Hunter T., Karin M., Chojkier M. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature. 1993 Aug 5;364(6437):544–547. doi: 10.1038/364544a0. [DOI] [PubMed] [Google Scholar]
  54. Wang Z. Y., Lin X. H., Nobuyoshi M., Deuel T. F. Identification of a single-stranded DNA-binding protein that interacts with an S1 nuclease-sensitive region in the platelet-derived growth factor A-chain gene promoter. J Biol Chem. 1993 May 15;268(14):10681–10685. [PubMed] [Google Scholar]
  55. Wegenka U. M., Buschmann J., Lütticken C., Heinrich P. C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol. 1993 Jan;13(1):276–288. doi: 10.1128/mcb.13.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES